Submit Deal

Christophe Weber

President and CEO at TAKEDA VENTURES

Investor

Deal Bio

Total Deals8

Valued Deals8

Total Value£53,505M

Avg. Deal Size£6,688M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (8)

Sort

IrelandUnited Kingdom

Biotechnology

PublicScheme

target

Shire

bidder

Takeda Pharmaceutical Company

£44,351m

154 dealmakers

Japan

Pharmaceuticals

AcquisitionPrivateMajority

target

XIIDRA

bidder

Novartis

£4,066m

52 dealmakers

United States

Pharmaceuticals

AcquisitionPrivateMajorityCross Border

target

Pvp Biologics

bidder

Takeda Pharmaceutical Company

£255m

12 dealmakers

DenmarkPoland

Pharmaceuticals

AcquisitionPrivateMajorityCross BorderDisposal

target

Takeda Pharmaceutical Company (otc Assets)

bidder

Orifarm Group

£530m

41 dealmakers

Japan

Health Care Services

PrivateAcquisitionMajorityPrivate EquityCross Border

target

Takeda Consumer Healthcare Company

bidder

Blackstone Group

£1,756m

38 dealmakers

Japan

Medical Equipment

MajorityPrivateCross BorderAcquisitionPrivate Equity

target

Takeda (tachosil)

bidder

Gtcr

£320m

78 dealmakers

United States

Biotechnology

Venture CapitalAcquisitionDomesticPrivateMajorityPrivate Equity

target

Velosbio

bidder

Merck & Co

£2,116m

55 dealmakers

United States

Biotechnology

AcquisitionDomesticPrivateMinorityPrivate EquityVenture Capital

target

ENSOMA

bidder

Arix Bioscience

£108m

19 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy